LeadIQ logo
Learn more at LeadIQ.com

Insights

Sustainable innovation Metagenomi's precision genetic medicines leverage metagenomics-derived genome editing, offering sustainable solutions and differentiation in the biotechnology industry.

Marked IPO success With a successful IPO launching at $15 per share and selling 6.25 million shares, Metagenomi shows potential for lucrative investments and partnership opportunities.

Legal challenges Recent class action lawsuits against Metagenomi could signal a potential need for legal services or support, presenting opportunities for law firms specializing in corporate litigation.

Growth potential Despite challenges, Metagenomi's revenue range of $10M - $50M and recent IPO indicate growth potential, offering opportunities for partnership, investment, and collaboration.

Competitive landscape Amidst similar companies in the biotechnology sector, understanding Metagenomi's competitive positioning and unique offerings can provide insights for strategic partnerships or competitive differentiation.

Similar companies to Metagenomi

Metagenomi Tech Stack

Metagenomi uses 8 technology products and services including LinkedIn Recruiter, CookieYes, Microsoft Outlook, and more. Explore Metagenomi's tech stack below.

  • LinkedIn Recruiter
    Applicant Tracking Systems
  • CookieYes
    Cookie Compliance
  • Microsoft Outlook
    Email
  • Plotly
    Javascript Graphics
  • SEOmatic
    Search Engines
  • Tailwind CSS
    UI Frameworks
  • Endurance Page Cache
    Web Platform Extensions
  • Apache HTTP Server
    Web Servers

Media & News

Metagenomi's Email Address Formats

Metagenomi uses at least 1 format(s):
Metagenomi Email FormatsExamplePercentage
First.Last@metagenomi.coJohn.Doe@metagenomi.co
80%
First@metagenomi.coJohn@metagenomi.co
17%
Fir.Last@metagenomi.coJoh.Doe@metagenomi.co
2%
Last@metagenomi.coDoe@metagenomi.co
1%

Frequently Asked Questions

Where is Metagenomi's headquarters located?

Minus sign iconPlus sign icon
Metagenomi's main headquarters is located at Emeryville, California 94608 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Metagenomi's stock symbol?

Minus sign iconPlus sign icon
Metagenomi is a publicly traded company; the company's stock symbol is MGX.

What is Metagenomi's official website and social media links?

Minus sign iconPlus sign icon
Metagenomi's official website is metagenomi.co and has social profiles on LinkedIn.

How much revenue does Metagenomi generate?

Minus sign iconPlus sign icon
As of October 2024, Metagenomi's annual revenue reached $15M.

What is Metagenomi's SIC code NAICS code?

Minus sign iconPlus sign icon
Metagenomi's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Metagenomi have currently?

Minus sign iconPlus sign icon
As of October 2024, Metagenomi has approximately 240 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: S. N.Chief Financial Officer: P. W.Vice President Cell Therapy: W. W.. Explore Metagenomi's employee directory with LeadIQ.

What industry does Metagenomi belong to?

Minus sign iconPlus sign icon
Metagenomi operates in the Biotechnology Research industry.

What technology does Metagenomi use?

Minus sign iconPlus sign icon
Metagenomi's tech stack includes LinkedIn RecruiterCookieYesMicrosoft OutlookPlotlySEOmaticTailwind CSSEndurance Page CacheApache HTTP Server.

What is Metagenomi's email format?

Minus sign iconPlus sign icon
Metagenomi's email format typically follows the pattern of . Find more Metagenomi email formats with LeadIQ.

How much funding has Metagenomi raised to date?

Minus sign iconPlus sign icon
As of October 2024, Metagenomi has raised $100M in funding. The last funding round occurred on Jan 05, 2023 for $100M.
Metagenomi

Metagenomi

Biotechnology ResearchCalifornia, United States201-500 Employees

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using our proprietary, comprehensive metagenomics-derived genome editing toolbox. We believe tools with capa­bil­i­ties that go beyond the cur­rent tech­nol­o­gy land­scape will be required in order to reach the full ther­a­peu­tic poten­tial of genome edit­ing. By har­ness­ing the pow­er of metage­nomics, the study of genomes recov­ered from uncul­ti­vat­ed organ­isms in the nat­ur­al envi­ron­ment, we are dis­cov­er­ing and devel­op­ing a suite of nov­el genome edit­ing tools with the poten­tial to make any desired ther­a­peu­tic gene edit, any­where in the human genome.

Section iconCompany Overview

Headquarters
Emeryville, California 94608 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MGX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconFunding & Financials

  • $100M

    Metagenomi has raised a total of $100M of funding over 7 rounds. Their latest funding round was raised on Jan 05, 2023 in the amount of $100M.

  • $10M$50M

    Metagenomi's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $100M

    Metagenomi has raised a total of $100M of funding over 7 rounds. Their latest funding round was raised on Jan 05, 2023 in the amount of $100M.

  • $10M$50M

    Metagenomi's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.